PCEC is thrilled to be partnering with Dendreon to present a webinar about immunotherapy for prostate cancer. Below is an outline of what will be covered in this presentation; there will also be time for questions at the end!
-What is immunotherapy and how can it benefit prostate cancer patients?
-When is immunotherapy an option for prostate cancer patients?
-What to expect when receiving Provenge.
-The clinical studies that led to the development of Provenge.